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Mitochondria, sub-cellular organelles originated from primary
endosymbiosis, play a vital role in the energy metabolism of
eukaryotic cells. Despite many aspects of ATP synthesis have been
delineated, regulatory mechanisms responsible for energy syn-
thesis and transfer still remain to be uncovered. In addition to
production of energy, mitochondria play a crucial role in entire
cell metabolism under both physiological and pathological con-
ditions through their participation in cell death, ion homeostasis,
reactive oxygen species (ROS) generation, redox signaling as
well as various intracellular signaling pathways. Studies over the
last 30 years provide strong evidence that mitochondria are the
nexus of various stresses which initiate cell death. The Research
Topic “Mitochondria: the cell powerhouse and nexus of stress”
presents state-of-the-art studies in mitochondrial research per-
formed by prominent experts from different laboratories around
the world. All 13 original research and review articles presented
in the topic are dedicated to several aspects of mitochondriology
includingmorphology, dynamics, metabolism, function, and reg-
ulation of these organelles under normal and pathophysiological
conditions.
It should be noted that despite many studies, numerous aspects
of mitochondrial functioning including the precise mechanisms
of protein synthesis in mitochondria remain unclear. In the study
presented by Koc et al. (2013) two novel small subunit pro-
teins, CHCHD1 and AURKAIP1, and the large subunit protein,
CRIF1 were characterized as new members of the mammalian
mitochondrial ribosome. Using siRNA knock-down studies the
authors demonstrated crucial roles of these proteins in mitochon-
drial protein synthesis, and revealed their significant effects on the
expression of mitochondrially encoded proteins. Also, interaction
of mitochondria with cytoplasmic proteins plays a causative role
in the regulation of energy metabolism and cell death. Recent
studies revealed interaction between elements of cytoskeleton and
mitochondria which may modulate energy synthesis and trans-
fer (Rostovtseva and Bezrukov, 2008; Guzun et al., 2011). The
review by Kuznetsov et al. (2013) summarizes studies on the
possible role of the cytoskeletal protein β-tubulin II in the reg-
ulation of mitochondrial metabolism, respiratory function, and
energy transfer. The authors suggest that interaction of β-tubulin
II with mitochondria can participate in the coupling of ATP-ADP
translocase (ANT), mitochondrial creatine kinase (MtCK), and
voltage-dependent anion channel (VDAC), and the ANT-MtCK-
VDAC complex is responsible for the efficient intracellular energy
transfer via the phosphocreatine pathway. Kaambre et al. (2013)
demonstrated the applicability of themetabolic control analysis as
a promising method for quantification of the flux control exerted
by different enzymatic steps in total metabolic network that can
be applied to study mechanisms of energy metabolism in human
breast and colorectal cancer cells. In addition to interaction with
other proteins/organelles, mitochondria per se can undergo struc-
tural modifications known as mitochondrial dynamics which is
associated with changes in their number, size, shape, and intra-
cellular localization. Mitochondrial dynamics is regulated by the
balanced action of various proteins responsible for fission and
fusion. These processes play also a key role in Ca2+ regulations,
as well as in biogenesis and the quality-control of mitochondria
under normal physiological conditions. Enhanced fission ofmito-
chondria is associated with mitochondrial fragmentation, which
is early sign of apoptosis in various cell stresses, including car-
diac diseases or ischemia-reperfusion injury although molecular
mechanisms of cell death induced by alterations in mitochon-
drial dynamics remain poorly understood. In this respect, the
study presented by Piquereau et al. (2013) discusses the possible
role of mitochondrial dynamics in mitochondria-mediated car-
diac dysfunction in ischemia/reperfusion and heart failure. The
authors highlight an importance of mitochondrial dynamics in
mitochondrial and cellular physiology.
It is known that a number of signaling molecules including
cytoplasmic and/or mitochondrial nitric oxide (NO) and ROS
participate in the regulation of mitochondrial metabolism.
Synthesis of NO from its precursor, nitrite increases during
hypoxia and enhanced NO through cGMP and can protect the
heart from ischemia/reperfusion injury. However, the mecha-
nisms of the synthesis of NO from nitrite in cardiomyocytes are
still not fully understood. Dungel et al. (2013) demonstrated that
mitochondria play a predominant role in nitrite reduction to NO,
leading to enhanced cGMP synthesis in cardiomyocytes. Notably,
mitochondrial ROS levels can be strongly regulated by several
distinct ROS-detoxification mechanisms. Expression of the major
ROS scavenger enzymes superoxide dismutase 2 (SOD2), catalase,
or sestrins is shown to be regulated by Forkhead box O (FOXO)
transcription factors. Hagenbuchner and Ausserlechner (2013)
discuss balanced action between Bim, mitochondrial architec-
ture, and ROS-detoxifying proteins that are regulated by FOXO.
Importantly, ROS-mediated modulation of various intracellular
signaling pathways can also be involved in the regulation of heart
contractility by the cardiac renin-angiotensin II-aldosterone
system (RAAS). Activation of RAAS enhances both cytoplasmic
and mitochondrial ROS generation although the cause-effect
relationship between these two sources for ROS remains to be elu-
cidated. De Giusti et al. (2013) presented a comprehensive review
on the relationship between chronic RAAS stimulation and mito-
chondrial ROS, and the possible role of sodium exchangers
in RAAS-mediated cardiac hypertrophy. Consequently,
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pharmacological inhibition of mitochondrial ROS generation
exerts a beneficial effect. Investigating ROS in skeletal muscles,
La Guardia et al. (2013) demonstrated that oxidative damage
induced by simvastatin in fibers from rat skeletal muscle is
associated with the enhanced mitochondrial superoxide gen-
eration, whereas pretreatment with L-carnitine prevented the
toxic effects of simvastatin. Interestingly, the study presented
by Canzoniero et al. (2013) shows that neurons expressing
large amounts of nNOS produce significantly less mitochon-
drial ROS in response to an excitotoxic challenge, thereby pro-
viding a potential mechanism for reduced cells vulnerability
to the excitotoxicity in patients with Huntington’s disease. It
is well-known that a number of various mitochondrial dis-
eases are associated with mutations, deletions, or deficiency of
genes encoding mitochondrial proteins. Deficiency of mitochon-
drial phospholipid cardiolipin in humans known as Barth syn-
drome is caused due to absence of mitochondrial acyl-transferase,
tafazzin that is essential for remodeling acyl chains of car-
diolipin. Powers et al. (2013) demonstrated that diminished
exercise capacity in tafazzin-knockdown mice can be explained
by the respiratory dysfunction of mitochondria. A causative
link between mitochondrial dysfunction and pathological disor-
ders has been shown using different other models of diseases.
For example, it has been shown that mitochondria dysfunc-
tion plays also an important role in developing of inflamma-
tion. Experiments using rat liver slices and isolated mitochondria
demonstrated that inflammation induced by inflammatorymedi-
ators resulted in mitochondrial dysfunction due to secondary
hypoxia (Weidinger et al., 2013). This study revealed hypoxia-
induced attenuation of complexes I and II function in response to
inflammation.
Accumulation of ROS along with Ca2+ overload can be con-
sidered as the major factors causing mitochondrial permeability
transition (mPT) associated with depolarization of mitochon-
drial membrane, ATP depletion and opening of non-specific
pathological mPT pores (mPTP). Irreversible high-conductance
mPTP opening plays a critical role in mitochondria-mediated cell
death. Although opening of mPTP is well-known phenomenon,
the molecular identity of the pores is still elusive. Previous
findings that the mPTP consists of VDAC and ANT were not
proven by genetic studies when VDAC- or ANT-null mitochon-
dria still exhibited a CsA-sensitive pore opening [reviewed in
Bernardi (2013)]. Cyclophilin D (CyP-D) is the only defined
component which plays an important regulatory role in pore
opening. Interestingly, recent studies demonstrated that CyP-D
binds the lateral stalk of the F0F1 ATP synthase and modulates its
activity (Giorgio et al., 2009). Furthermore, the authors provided
strong evidence that dimers of the F0F1 ATP synthase incorpo-
rated into lipid bilayers form Ca2±-activated channels with the
key features of the mPTP (Bernardi, 2013; Giorgio et al., 2013).
The review by Javadov and Kuznetsov (2013) summarizes and
discusses the possible mechanisms of the activation of CyP-D to
interact with a target protein in the inner mitochondrial mem-
brane and initiate opening of the mPTP. Notably, physiological
(low-conductance) mPTP opening can regulate mitochondrial
Ca2+ homeostasis through modulation of Ca2+ efflux, and gen-
erate and convey calcium signals from one mitochondrion to
another (reviewed in Brenner and Moulin, 2012). Indeed, the
low-conductance mPTP is one of dozens of channels/exchangers
which regulate ion homeostasis in mitochondria. In this aspect,
Na+/H+ exchanger 1 (NHE1) is one of most interesting ion
transporters recently found in the mitochondrial inner mem-
brane (Javadov et al., 2011; Villa-Abrille et al., 2011). Although
NHE1 is the main transporter of the plasma membrane regu-
lating H+ concentration in cytoplasm, its role in mitochondrial
physiology is still unknown. In this Topic, the potential role
of mitochondrial NHE1 as a target to prevent cardiac diseases
such as ischemia/reperfusion and heart failure was described by
Alvarez and Villa-Abrille (2013).
In conclusion, this Frontiers Review Topic highlights several
important aspects of mitochondrial research under normal and
pathological/stressful conditions. This will hopefully be useful
for further understanding of mitochondrial biology as well as
molecular mechanisms of mitochondria-mediated cell dysfunc-
tion aiming to develop a number of new therapeutic approaches
for the treatment of various human diseases by targeting mito-
chondria.
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